Siegfried Holding AG (SGFEF) Research

Siegfried Holding AG is a global enterprise active in the life sciences industry. The company is dedicated to developing and manufacturing active pharmaceutical ingredients (APIs) and their intermediate compounds, as well as a diverse range of finished drug products. These include solid oral medications, sterile and aseptically filled injectable solutions, ophthalmic preparations, and inhalable treatments. It offers extensive contract development and manufacturing (CDMO) services, which span pharmaceutical and analytical development, process and analytical transfer, commercial-scale production and packaging, and the provision of materials for clinical trials along with process scale-up. Siegfried also supplies specific APIs and controlled substances, particularly those used in anesthetics, pain relief, and treatments for central nervous system and respiratory conditions. Furthermore, the company licenses solid oral and sterile pharmaceutical products, meticulously prepares registration dossiers, and provides common technical documents for various offerings. Founded in 1873, Siegfried Holding AG is headquartered in Zofingen, Switzerland.

Open Siegfried Holding AG (SGFEF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.